This company develops and produces biosimilar products, ethical drugs, over the counter drugs, and other related products. They have a diverse pipeline of biosimilars that treat different diseases and disorders through multiple therapeutic modalities.
Latest News
- Celltrion Reinforces Commitment To UK Biosimilars Market With New HQ - insights.citeline.com
- [Bio USA] Celltrion deepens global ties, unveils R&D vision at Bio USA - The Korea Herald
- [Bio USA] Celltrion deepens global ties, unveils R&D vision at Bio USA - theinvestor.co.kr
- Celltrion announced on the 20th that it participated in the world's largest bio exhibition "2025 Bio.. - 매일경제
- [BIO USA 2025] Celltrion advances global expansion with 150+ partnership talks - koreabiomed.com
- Remicade Market Generated Opportunities, Future Scope - openPR.com
- Celltrion opens new UK headquarters in Uxbridge to drive long-term growth - Pharmafile
- Korean biopharma firm Celltrion opens new UK headquarters in Uxbridge - BioSpectrum Asia
- Celltrion opens new UK headquarters in Uxbridge, UK - Yahoo Finance
- Celltrion opens new UK headquarters in Uxbridge, UK - bastillepost.com
- Celltrion opens new UK headquarters in Uxbridge, UK - Bluefield Daily Telegraph
- Celltrion opens new UK headquarters in Uxbridge, UK - itemonline.com
- Celltrion opens new UK headquarters in Uxbridge, UK - Bakersfield.com
- Int’l journal publishes therapeutic equivalence of Celltrion’s Omlyclo - 매일경제
- KRX Short Interest Weekly (Jun 13th): Lg Energy Solution, Celltrion, Ecoprobm, Hanmi Semicon - Smartkarma
